Your browser doesn't support javascript.
loading
Dupilumab improves clinical symptoms in children with Netherton syndrome by suppressing Th2-mediated inflammation.
Yan, Shi; Wu, Xuege; Jiang, Jinqiu; Yu, Shijuan; Fang, Xiao; Yang, Huan; Bai, Xiaoming; Wang, Hua; Luo, Xiaoyan.
Afiliación
  • Yan S; Department of Dermatology, Children's Hospital of Chongqing Medical University Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.
  • Wu X; Chongqing Key Laboratory of Child Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China.
  • Jiang J; Department of Dermatology, Children's Hospital of Chongqing Medical University Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.
  • Yu S; Chongqing Key Laboratory of Child Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China.
  • Fang X; Department of Dermatology, Children's Hospital of Chongqing Medical University Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.
  • Yang H; Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
  • Bai X; Department of Dermatology, Children's Hospital of Chongqing Medical University Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.
  • Wang H; Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
  • Luo X; Department of Dermatology, Children's Hospital of Chongqing Medical University Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.
Front Immunol ; 13: 1054422, 2022.
Article en En | MEDLINE | ID: mdl-36569942
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades de la Piel / Síndrome de Netherton Tipo de estudio: Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Límite: Child / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades de la Piel / Síndrome de Netherton Tipo de estudio: Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Límite: Child / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza